<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">340353</id>
  <title nil="true"/>
  <common-name>4-[amino-hydroxy-(3,4,5-trimethoxyphenyl)methyl]-n-(3,4,5-trimethoxyphenyl)-2,3-dihydropyrazine-1-carboxamide</common-name>
  <description>4-[amino-hydroxy-(3,4,5-trimethoxyphenyl)methyl]-n-(3,4,5-trimethoxyphenyl)-2,3-dihydropyrazine-1-carboxamide is a chemical compound with the formula C24H32N4O8. With an average molecular weight of 504.50 g/mol, 4-[amino-hydroxy-(3,4,5-trimethoxyphenyl)methyl]-n-(3,4,5-trimethoxyphenyl)-2,3-dihydropyrazine-1-carboxamide is a heavy molecule.</description>
  <cas>68061-05-2</cas>
  <pubchem-id>3051893</pubchem-id>
  <chemical-formula>C24H32N4O8</chemical-formula>
  <weight>504.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T23:55:19Z</created-at>
  <updated-at type="dateTime">2026-08-30T23:55:19Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=CC(=C1OC)OC)C(N)(N2CCN(C=C2)C(=O)NC3=CC(=C(C(=C3)OC)OC)OC)O</moldb-smiles>
  <moldb-formula>C24H32N4O8</moldb-formula>
  <moldb-inchi>InChI=1S/C24H32N4O8/c1-31-17-11-15(12-18(32-2)21(17)35-5)24(25,30)28-9-7-27(8-10-28)23(29)26-16-13-19(33-3)22(36-6)20(14-16)34-4/h7,9,11-14,30H,8,10,25H2,1-6H3,(H,26,29)</moldb-inchi>
  <moldb-inchikey>XSNVNUSUAQVMLQ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.222014</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>0.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM336246</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[amino-hydroxy-(3,4,5-trimethoxyphenyl)methyl]-n-(3,4,5-trimethoxyphenyl)-2,3-dihydropyrazine-1-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>N-phenylureas</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0290767</sync-id>
  <structure-inchikey>XSNVNUSUAQVMLQ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000000800000020000000000000000001000000200000004100000020008000000004000000000000000000000000000000000000000000000000000000000000000010000000000000200000100001000000000000000200000000000100000002400000001000000000000201000000000000000000000000000000400000000000000000008000800010200000000000000000000000000000000000000000000800000c0001000040000000000000008000000000000080000000000000010008001000000000000000000000000000000000000000000000008000408000000040000800080408000000000020000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7414c0008d32866081001b608138a2001900140081052010a03d20c0823448cc6c020052138000000300410800c00000046002b5508d3221016c653980b04010c7110c801288160000901040127202000804c58051211f3340040462402249040c38052f004c922040081480ddb4004d208680528101e1065198044002710002104030984ef0820808860250482c0288391d181244409e8a5000082060c0008401d3121310b8c22002040960097c35144ac000028941084012064a104cc00212a01000a404f8003219808480571102910c010010030050000d600200288003409038411418c1212011000003599220c20050043085c2040e110810807201060b</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:40:38Z</structure-indexed-at>
</compound>
